anayamalik, Author at European Medical Journal - Page 51 of 83

The Evolution of Tuberculosis Isolation Practices

A new study explores the evolution of tuberculosis isolation, from early misconceptions to modern airborne transmission guidelines. See how TB control measures have changed.

Navigating Challenges in Cardiac Device Infections

Cardiac implantable electronic device infections (CIEDIs) pose significant challenges in diagnosis and management for healthcare professionals.

Do Obesity, Diabetes, Smoking Affect Surgical Outcomes in Hidradenitis Suppurativa?

A recently published review examined the impact of obesity, diabetes, and smoking on surgical outcomes for patients with hidradenitis suppurativa (HS).

Cognitive Activity in Midlife and Late Life Lowers Alzheimer’s Risk

Engaging in mentally stimulating activities in midlife and late life is linked to a lower risk of Alzheimer’s disease (AD), according to a study from the Chicago Health and Aging Project.

How To Better Guide Patient Management in Aggressive Lymphoma: New Data on PET/CT

18F-FDG PET and PET/CT scans show strong diagnostic accuracy in detecting histological transformations (HT) in indolent lymphomas, including Richter’s transformation (RT) in chronic lymphocytic leukemia (CLL), according to a new meta-analysis.

Pediatric CF Therapy Enhances Airway Function

A real-world study from the Netherlands has shared the benefits of lumacaftor/ivacaftor (lum/iva) in children with cystic fibrosis (CF) homozygous for the F508del mutation.

Cardiovascular Imaging Breakthroughs for Rheumatic Disease

A recent study evaluated the advantages and limitations of various noninvasive imaging modalities in diagnosing cardiovascular disease (CVD) in patients with autoimmune rheumatic diseases (ARDs).

Future of AI in Aesthetic Skin Care

Recent advancements in artificial intelligence (AI) are reshaping dermatology, particularly in diagnosing skin diseases like skin cancer.

Perinatal Lead Exposure Linked to Lower Vaccine Antibody Response

Emerging research highlights critical windows of susceptibility to lead exposure that may reduce antibody responses to childhood vaccines, raising concerns for immune health.

AI Tool Using Blood Tests Predicts Cancer Immunotherapy Success

A machine learning model, SCORPIO, has shown promise in predicting the success of immune checkpoint inhibitors (ICIs) for patients with cancer.